Inhibition of amyloid fibril formation of β-amyloid peptides via the amphiphilic surfactants

被引:78
作者
Wang, SSS [1 ]
Chen, YT [1 ]
Chou, SW [1 ]
机构
[1] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2005年 / 1741卷 / 03期
关键词
Alzheimer's disease; beta-amyloid; fibril; aggregation; inhibitor;
D O I
10.1016/j.bbadis.2005.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-amyloid peptide (A beta) is the major proteinacious constituent of senile plaques in Alzheimer's disease and is believed to be responsible for the neurodegeneration process associated with the disease. While the actual size of the aggregated species responsible for A beta neurotoxicity and fibrillogenesis mechanism(s) remain unknown, retardation of A aggregation still holds assurance as an effective strategy in reducing A beta-elicited toxicity. The research presented here is aimed at examining the inhibitory effect of two amphiphilic surfactants, di-C6-PC and di-C7-PC, on the in vitro fibrillogenesis process of A beta(1-40) peptides at physiological pH (pH 7.2). Using ThT-induced fluorescence, turbidity, Congo red binding, and circular dichroism spectroscopy studies, our research demonstrated that the inhibition of A beta(1-40) fibril formation was di-C6-PC and di-C7-PC concentration-dependent. The best inhibitory action on fibril formation was observed when A beta was incubated with di-C7-PC at 100 mu M over time. We believe that the outcome from this work will aid in the development and/or design of potential inhibitory agents against amyloid formation associated with Alzheimer's and other amyloid diseases. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:307 / 313
页数:7
相关论文
共 42 条
[1]   BETA-AMYLOID NEUROTOXICITY IN HUMAN CORTICAL CULTURE IS NOT MEDIATED BY EXCITOTOXINS [J].
BUSCIGLIO, J ;
YEH, J ;
YANKNER, BA .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (04) :1565-1568
[2]   Targeting the neurotoxic species in Alzheimer's disease:: inhibitors of Aβ oligomerization [J].
De Felice, FG ;
Vieira, MNN ;
Saraiva, LM ;
Figueroa-Villar, JD ;
Garcia-Abreu, J ;
Liu, R ;
Chang, L ;
Klein, WL ;
Ferreira, ST .
FASEB JOURNAL, 2004, 18 (12) :1366-1372
[3]   Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease [J].
Defelice, FG ;
Ferreira, ST .
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2002, 74 (02) :265-284
[4]   Current concepts - Evaluation of dementia [J].
Geldmacher, DS ;
Whitehouse, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (05) :330-336
[5]   MOLECULAR DETERMINANTS OF AMYLOID DEPOSITION IN ALZHEIMERS-DISEASE - CONFORMATIONAL STUDIES OF SYNTHETIC BETA-PROTEIN FRAGMENTS [J].
HALVERSON, K ;
FRASER, PE ;
KIRSCHNER, DA ;
LANSBURY, PT .
BIOCHEMISTRY, 1990, 29 (11) :2639-2644
[6]   Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons [J].
Hartley, DM ;
Walsh, DM ;
Ye, CPP ;
Diehl, T ;
Vasquez, S ;
Vassilev, PM ;
Teplow, DB ;
Selkoe, DJ .
JOURNAL OF NEUROSCIENCE, 1999, 19 (20) :8876-8884
[7]   Pentapeptide amides interfere with the aggregation of β-amyloid peptide of Alzheimer's disease [J].
Hetényi, C ;
Szabó, Z ;
Klement, T ;
Datki, Z ;
Körtvélyesi, T ;
Zarándi, M ;
Penke, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 292 (04) :931-936
[8]   AGGREGATION STATE AND NEUROTOXIC PROPERTIES OF ALZHEIMER BETA-AMYLOID PEPTIDE [J].
HOWLETT, DR ;
JENNINGS, KH ;
LEE, DC ;
CLARK, MSG ;
BROWN, F ;
WETZEL, R ;
WOOD, SJ ;
CAMILLERI, P ;
ROBERTS, GW .
NEURODEGENERATION, 1995, 4 (01) :23-32
[9]   The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways [J].
Kelly, JW .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1998, 8 (01) :101-106
[10]   Alternative conformations of amyloidogenic proteins govern their behavior [J].
Kelly, JW .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1996, 6 (01) :11-17